Phenols
Chemscene ChemScene | 4-Fluororesorcinol | 5G | CS-W003112 | 0.98 | 103068-41-3| MFCD03789074 | 128.1
ChemScene | 4-Fluororesorcinol | 5G | CS-W003112 | 0.98 | 103068-41-3| MFCD03789074 | 128.1
eMolecules 63286-28-2 | 2-Chloro-3-hydrazinopyrazine | Oakwood Chemicals | MFCD08272804 | 144.560 | C4H5ClN4 | 95.000 | NNc1nccnc1Cl | 1g | 480135388
2-Chloro-3-hydrazinopyrazine | Oakwood Chemicals | 63286-28-2 | MFCD08272804 | 144.560 | C4H5ClN4 | 95.000 | NNc1nccnc1Cl | 1g | 480135388
eMolecules 680-31-9 | Hexamethylphosphoramide | AA Blocks LLC | MFCD00008303 | 179.204 | C6H18N3OP | 0.000 | CN(C)P(=O)(N(C)C)N(C)C | 25g | 448665035
Hexamethylphosphoramide | AA Blocks LLC | 680-31-9 | MFCD00008303 | 179.204 | C6H18N3OP | 0.000 | CN(C)P(=O)(N(C)C)N(C)C | 25g | 448665035
Medchemexpress LLC Adamantan-2-one | 700-58-3 | MFCD00074737 | ≥98.0% | 150.22 g/mol | C10H14O | 100g
Adamantane is a compound used in the synthesis of N-Boc-1 2 4-trioxane[1]
(C(C)C)C(C)C | 100g | 837433968](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000488521.jpg-250.jpg)
eMolecules 111409-79-1 | (Bromoethynyl)triisopropylsilane | ChemScene | MFCD11036302 | 261.278 | C11H21BrSi | 97.000 | CC(C)[Si](C#CBr)(C(C)C)C(C)C | 100g | 837433968
(Bromoethynyl)triisopropylsilane | ChemScene | 111409-79-1 | MFCD11036302 | 261.278 | C11H21BrSi | 97.000 | CC(C)[Si](C#CBr)(C(C)C)C(C)C | 100g | 837433968
Cambridge Isotope Laboratories 1 2 3 6 7 8-Hexabromodibenzo-p-dioxin (unlabeled) 5 ug/mL in nonane toluene (70 30) 1 2 mL
1 2 3 6 7 8-Hexabromodibenzo-p-dioxin (unlabeled) 5 ug/mL in nonane toluene (70 30) 1 2 mL
Apexbio Technology LLC TC-H 106 937039-45-7 50mg
TC-H 106 (CAS 937039-45-7) is a selective inhibitor of class I histone deacetylases (HDACs) targeting HDAC1 HDAC2 HDAC3 and HDAC8 with reported IC50 values of 150 nM 760 nM 370 nM and 5000 nM respectively By inhibiting HDAC activity TC-H 106 interferes with the removal of acetyl groups from histone lysine residues thereby modulating chromatin structure and gene expression In cellular assays TC-H 106 increases histone H3 acetylation in lymphoblastoid cells derived from Friedreich s ataxia (FRDA) patients and enhances frataxin mRNA levels in FRDA mouse models These findings highlight its application in studying epigenetic mechanisms and therapeutic approaches related to HDAC inhibition particularly in neurodegenerative disease models
Apexbio Technology LLC TC-H 106 937039-45-7 10mg
TC-H 106 (CAS 937039-45-7) is a selective inhibitor of class I histone deacetylases (HDACs) targeting HDAC1 HDAC2 HDAC3 and HDAC8 with reported IC50 values of 150 nM 760 nM 370 nM and 5000 nM respectively By inhibiting HDAC activity TC-H 106 interferes with the removal of acetyl groups from histone lysine residues thereby modulating chromatin structure and gene expression In cellular assays TC-H 106 increases histone H3 acetylation in lymphoblastoid cells derived from Friedreich s ataxia (FRDA) patients and enhances frataxin mRNA levels in FRDA mouse models These findings highlight its application in studying epigenetic mechanisms and therapeutic approaches related to HDAC inhibition particularly in neurodegenerative disease models